Tumor suppressor interferonregulatory factor 1 counteracts the germinal center reaction driven by a cancerassociated gammaherpesvirus

Journal of Virology

Volumn 90, Issue 6, 2016, Pages 2818-2829

  Mboko, Wadzanai P ^a   Olteanu, Horatiu ^a   Ray, Avijit ^b   Xin, Gang ^b   Darrah, Eric J ^a   Kumar, Suresh N ^a   Kulinski, Joseph M ^a   Cui, Weiguo ^b   Dittel, Bonnie N ^b   Gauld, Stephen B ^c   Tarakanova, Vera L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c ABBVIE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CONTROLLED STUDY; GAMMAHERPESVIRUS; GERMINAL CENTER; HENDRA VIRUS INFECTION; HERPESVIRIDAE; HUMAN; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRAL TROPISM; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; GAMMAHERPESVIRINAE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; PATHOLOGY; SPLEEN; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; GAMMAHERPESVIRINAE; GERMINAL CENTER; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTOR-1; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; SPLEEN;

EID: 84961115924     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02774-15     Document Type: Article

References (43)

1. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10.1038/nature09907.
2. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, Garcia-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695. http://dx.doi.org/10.1038/nature14555.
3. Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M, Jr, Diamond MS. 2011. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. PLoS Pathog 7:e1002230. http://dx.doi.org/10.1371/journal.ppat.1002230.
4. Nair S, Michaelsen-Preusse K, Finsterbusch K, Stegemann-Koniszewski S, Bruder D, Grashoff M, Korte M, Koster M, Kalinke U, Hauser H, Kroger A. 2014. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog 10:e1003999. http://dx.doi.org/10.1371/journal.ppat.1003999.
5. Maloney NS, Thackray LB, Goel G, Hwang S, Duan E, Vachharajani P, Xavier R, Virgin HW. 2012. Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-gamma-mediated inhibition of norovirus replication in macrophages. J Virol 86:12655-12664. http://dx.doi.org/10.1128/JVI.01564-12.
6. Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sokmen M. 2013. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-gamma with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C. Int J Infect Dis 17:e44-e49. http://dx.doi.org/10.1016/j.ijid.2012.08.004.
7. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA. 2007. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21:1091-1101. http://dx.doi.org/10.1097/QAD.0b013e3280ef6ae1.
8. Nozawa H, Oda E, Nakao K, Ishihara M, Ueda S, Yokochi T, Ogasawara K, Nakatsuru Y, Shimizu S, Ohira Y, Hioki K, Aizawa S, Ishikawa T, Katsuki M, Muto T, Taniguchi T, Tanaka N. 1999. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev 13:1240-1245. http://dx.doi.org/10.1101/gad.13.10.1240.
9. Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 59:489-510. http://dx.doi.org/10.1007/s00262-009-0804-6.
10. Cesarman E. 2011. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett 305:163-174. http://dx.doi.org/10.1016/j.canlet.2011.03.003.
11. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97. http://dx.doi.org/10.1016/S0092-8674(05)80086-8.
12. Tarakanova VL, Stanitsa E, Leonardo SM, Bigley TM, Gauld SB. 2010. Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo. Virology 405:50-61. http://dx.doi.org/10.1016/j.virol.2010.05.027.
13. Kulinski JM, Darrah EJ, Broniowska KA, Mboko WP, Mounce BC, Malherbe LP, Corbett JA, Gauld SB, Tarakanova VL. 2015. ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection. Virology 483:264-274. http://dx.doi.org/10.1016/j.virol.2015.04.026.
14. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD, Gompels UA. 1990. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 71:1365-1372. http://dx.doi.org/10.1099/0022-1317-71-6-1365.
15. Tarakanova VL, Suarez FS, Tibbetts SA, Jacoby M, Weck KE, Hess JH, Speck SH, Virgin HW. 2005. Murine gammaherpesvirus 68 infection induces lymphoproliferative disease and lymphoma in BALB 2 microglobulin-deficient mice. J Virol 79:14668-14679. http://dx.doi.org/10.1128/JVI.79.23.14668-14679.2005.
16. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ, Speck SH. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894-5904.
17. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. B cells regulate murine gammaherpesvirus 68 latency. J Virol 73:4651-4661.
18. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 73:3273-3283.
19. Dutia BM, Allen DJ, Dyson H, Nash AA. 1999. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology 261:173-179. http://dx.doi.org/10.1006/viro.1999.9834.
20. Barton E, Mandal P, Speck SH. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol 29: 351-397. http://dx.doi.org/10.1146/annurev-immunol-072710-081639.
21. Roughan JE, Thorley-Lawson DA. 2009. The intersection of Epstein-Barr virus with the germinal center. J Virol 83:3968-3976. http://dx.doi.org/10.1128/JVI.02609-08.
22. Coleman CB, Nealy MS, Tibbetts SA. 2010. Immature and transitional B cells are latency reservoirs for a gammaherpesvirus. J Virol 84:13045-13052. http://dx.doi.org/10.1128/JVI.01455-10.
23. Collins CM, Boss JM, Speck SH. 2009. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol 83:6484-6493. http://dx.doi.org/10.1128/JVI.00297-09.
24. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165:1074-1081. http://dx.doi.org/10.4049/jimmunol.165.2.1074.
25. Flano E, Kim IJ, Woodland DL, Blackman MA. 2002. Gammaherpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196:1363-1372. http://dx.doi.org/10.1084/jem.20020890.
26. Liang X, Collins CM, Mendel JB, Iwakoshi NN, Speck SH. 2009. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog 5:e1000677. http://dx.doi.org/10.1371/journal.ppat.1000677.
27. Willer DO, Speck SH. 2003. Long-term latent murine gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol 77:8310-8321. http://dx.doi.org/10.1128/JVI.77.15.8310-8321.2003.
28. Collins CM, Speck SH. 2014. Expansion of murine gammaherpesvirus latently infected B cells requires T follicular help. PLoS Pathog 10: e1004106. http://dx.doi.org/10.1371/journal.ppat.1004106.
29. Kuppers R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801-812. http://dx.doi.org/10.1038/nri1201.
30. Connett JM, Badri L, Giordano TJ, Connett WC, Doherty GM. 2005. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J Interferon Cytokine Res 25:587-594. http://dx.doi.org/10.1089/jir.2005.25.587.
31. Kuroboshi H, Okubo T, Kitaya K, Nakayama T, Daikoku N, Fushiki S, Honjo H. 2003. Interferon regulatory factor-1 expression in human uterine endometrial carcinoma. Gynecol Oncol 91:354-358. http://dx.doi.org/10.1016/S0090-8258(03)00515-8.
32. Wang Y, Liu DP, Chen PP, Koeffler HP, Tong XJ, Xie D. 2007. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res 67:2535-2543. http://dx.doi.org/10.1158/0008-5472.CAN-06-3530.
33. Singavi AK, Harrington AM, Fenske TS. 2015. Post-transplant lymphoproliferative disorders. Cancer Treat Res 165:305-327. http://dx.doi.org/10.1007/978-3-319-13150-4_13.
34. Kuo TC, Calame KL. 2004. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J Immunol 173:5556-5563. http://dx.doi.org/10.4049/jimmunol.173.9.5556.
35. Piya S, Moon AR, Song PI, Hiscott J, Lin R, Seol DW, Kim TH. 2011. Suppression of IRF4 by IRF1, 3, and 7 in Noxa expression is a necessary event for IFN-gamma-mediated tumor elimination. Mol Cancer Res 9:1356-1365. http://dx.doi.org/10.1158/1541-7786.MCR-11-0185.
36. Pamment J, Ramsay E, Kelleher M, Dornan D, Ball KL. 2002. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21:7776-7785. http://dx.doi.org/10.1038/sj.onc.1205981.
37. Mboko WP, Mounce BC, Emmer J, Darrah E, Patel SB, Tarakanova VL. 2014. Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells. J Virol 88:6993-7004. http://dx.doi.org/10.1128/JVI.00638-14.
38. Yamada G, Ogawa M, Akagi K, Miyamoto H, Nakano N, Itoh S, Miyazaki J, Nishikawa S, Yamamura K, Taniguchi T. 1991. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci U S A 88:532-536. http://dx.doi.org/10.1073/pnas.88.2.532.
39. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S, Taniguchi T. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogenactivated T lymphocytes. Nature 376:596-599. http://dx.doi.org/10.1038/376596a0.
40. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816-818. http://dx.doi.org/10.1038/382816a0.
41. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. 2010. Virus-plussusceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-1145. http://dx.doi.org/10.1016/j.cell.2010.05.009.
42. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971. http://dx.doi.org/10.1126/science.8438156.
43. Zimring JC, Goodbourn S, Offermann MK. 1998. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701-707.